Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Bacterial DNA amplifies neutrophilic inflammation in IL-17-exposed airways

Nastaran Mues, Richard J. Martin, Rafeul Alam, Niccolette Schaunaman, Kris Genelyn Dimasuay, Christena Kolakowski, Clyde J. Wright, Lijun Zheng, Hong Wei Chu
ERJ Open Research 2023 9: 00474-2022; DOI: 10.1183/23120541.00474-2022
Nastaran Mues
1Department of Medicine, National Jewish Health, Denver, CO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard J. Martin
1Department of Medicine, National Jewish Health, Denver, CO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rafeul Alam
1Department of Medicine, National Jewish Health, Denver, CO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Niccolette Schaunaman
1Department of Medicine, National Jewish Health, Denver, CO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kris Genelyn Dimasuay
1Department of Medicine, National Jewish Health, Denver, CO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kris Genelyn Dimasuay
Christena Kolakowski
1Department of Medicine, National Jewish Health, Denver, CO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clyde J. Wright
2Department of Pediatrics, Children's Hospital of Colorado, University of Colorado School of Medicine, Aurora, CO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lijun Zheng
2Department of Pediatrics, Children's Hospital of Colorado, University of Colorado School of Medicine, Aurora, CO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hong Wei Chu
1Department of Medicine, National Jewish Health, Denver, CO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Figures

  • Tables
  • Supplementary Materials
  • FIGURE 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1

    Increased bacterial DNA in bronchoalveolar lavage fluid (BALF) of neutrophilic asthma subjects. a) Bacterial DNA levels in BALF of normal subjects, non-neutrophilic asthma subjects and neutrophilic asthma subjects. b) Correlations between bacterial DNA and neutrophils and c) interleukin (IL)-8 in BALF of non-neutrophilic asthma subjects (black open circles) and neutrophilic asthma subjects (red open circles). The horizontal bars represent medians.

  • FIGURE 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2

    Bacterial DNA amplified interleukin (IL)-8 production in IL-17-exposed human airway epithelial cells and lung macrophages. a) Primary normal human small airway epithelial cells (n=5 subjects) grown at air–liquid interface. b) Primary normal human tracheobronchial epithelial cells under submerged culture (n=4 subjects). c) Primary normal human alveolar macrophages (n=5 subjects). Cells were stimulated with or without IL-17 for 24 h and then treated with or without bacterial DNA for 48 h. (−) indicates controls. The horizontal bars represent medians.

  • FIGURE 3
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3

    Bacterial DNA increased neutrophilic inflammation in interleukin (IL)-17-exposed mouse lungs. Wild-type C57BL/6 mice (n=10 to 12 mice per group) from two independent experiments were intranasally challenged with IL-17 (3 µg/mouse) for 24 h, followed by DNA (1 µg/mouse) derived from nontypeable Haemophilus influenzae. After 24 h, bronchoalveolar lavage fluid (BALF) was analysed for a) % of neutrophils, b) total numbers of neutrophils and c) neutrophil chemoattractant LIX. (−) indicates controls. The horizontal bars represent medians.

  • FIGURE 4
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4

    Role of DNA signalling in bacterial DNA-mediated amplification of neutrophil chemokines. a) Primary normal human small airway epithelial cells (n=4 subjects) under submerged culture were treated with interleukin (IL)-17 for 24 h, and then exposed to bacterial DNA±A151 or A151 negative control (ctrl) for 48 h. b) Human tracheobronchial epithelial cells transduced with lentivirus containing the STING sgRNA or scramble (SCR) control sgRNA plasmid construct were treated with IL-17 for 24 h, and then exposed to bacterial DNA under the submerged condition for 48 h. c) Mouse tracheal epithelial cells (mTEC) isolated from wild-type (C57BL/6) and Toll-like receptor 9 (TLR9) knockout (KO) mice were grown at air–liquid interface and stimulated with or without IL-17 for 24 h and then treated with/without bacterial DNA for 48 h. d) Bone marrow-derived macrophages from wild-type and TLR9 KO mice were cultured and stimulated with or without IL-17 and exposed to either bacterial DNA (bDNA) or mammalian DNA (mDNA) extracted from mTEC. n=3 to 4 replicates. (−) indicates controls. The horizontal bars represent means.

  • FIGURE 5
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5

    Toll-like receptor 9 (TLR9) conditional knockout in myeloid cells downregulates airway neutrophilic inflammation in mice exposed to interleukin (IL)-17 and bacterial DNA. LysMCre+TLR9fl/fl and LysMCre–TLR9fl/fl mice were challenged with IL-17 (3 µg/mouse) in 0.01% bovine serum albumin (BSA) or 0.01% BSA (control) for 24 h, followed by bacterial DNA (1 µg/mouse) challenge or Tris-EDTA buffer via intranasal inoculation. After 24 h of DNA exposure, bronchoalveolar lavage fluid (BALF) was collected and analysed for a,b) neutrophils and c) neutrophil chemoattractant LIX. (−) indicates controls. The horizontal bars represent medians.

  • FIGURE 6
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 6

    Interleukin (IL)-36γ in human bronchoalveolar lavage fluid (BALF) and cultured airway epithelial cells. a) Representative Western blot images and densitometry of IL-36γ protein in BALF from healthy control subjects, non-neutrophilic asthma (NNA) and neutrophilic asthma (NA) subjects. Each dot represents one subject. b) IL-36γ Western blot images and densitometry in supernatants of cultured primary normal human small airway epithelial cells (n=5 subjects) exposed to IL-17 for 24 h, and then bacterial DNA for 48 h. c) Primary normal human small airway epithelial cells were stimulated with or without IL-17 for 24 h and then treated with/without bacterial DNA in the presence of an IgG isotype control or an IL-36γ neutralising antibody for 48 h. (−) indicates controls. The horizontal bars represent medians.

  • FIGURE 7
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 7

    Recombinant human DNase I reduces lung neutrophilic inflammation in interleukin (IL)-17-challenged and nontypeable Haemophilus influenzae (NTHi)-infected mice. Wild-type C57BL/6 mice were challenged with IL-17 (3 µg/mouse), NTHi (107 CFU/mouse) and DNase I (5 µg/mouse) via intranasal inoculation. After 24 h, bronchoalveolar lavage fluid (BALF) was collected for analysing total numbers of a) neutrophils, b) neutrophil chemoattractant LIX, c) count of colony forming units (CFU) in the right lung tissue homogenate and d) IL-36γ protein using Western blot. (−) indicates controls. The horizontal bars represent medians.

  • FIGURE 8
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 8

    Proposed mechanisms by which bacterial DNA and interleukin (IL)-17 cooperate to amplify airway neutrophilic inflammation. IL-17 binds to its receptor and induces IL-36γ expression. IL-36γ binds to its heterodimeric receptor complex, subsequently recruits MyD88, activates MAPK and NF-κB signalling cascades, and induces IL-8 and neutrophilic inflammation. Bacterial DNA binds to TLR9, leading to activation of MAPK and NF-κB signalling pathways. Activation of IL-36γ signalling also results in TLR9 translocation, leading to further activation of TLR9 signalling and amplification of neutrophilic inflammation. MyD88: adaptor protein myeloid differentiated protein 88; IRAK1: interleukin-1 receptor-associated kinase 1; MAPK: mitogen-activated protein kinase; NF-κB: nuclear transcription factor kappa B; TLR9: Toll-like receptor 9.

Tables

  • Figures
  • Supplementary Materials
  • TABLE 1

    Characteristics of healthy and asthma subjects

    Healthy subjectsNon-neutrophilic asthma (NNA)Neutrophilic asthma (NA)p-value
    Subjects n201416
    Age years33.6±2.042.2±3.751.8±3.9<0.01 NA versus healthy, >0.05 NA versus NNA
    Sex M/F n7/136/88/80.33 NA versus healthy and NNA
    FEV1 % predicted96.0±2.775.4±5.561.2±5.0<0.01 NA versus healthy,
    0.07 NA versus NNA
    BMI kg·m−229.7±1.327.5±1.529.3±1.50.55 NA versus healthy and NNA
    FENO ppb23.2±3.336.3±5.952.7±13.10.02 NA versus healthy, >0.05 NA versus NNA
    ACT scoreN/A17.5±1.317.1±1.60.84 NA versus NNA
    Inhaled corticosteroid useNoneHigh dose (3), low dose (11)High dose (9), low dose (5), medium dose (1), unknown (1)0.11 NA versus NNA
    Neutrophils % in BALF1.9±0.31.4±0.215.3±4.6<0.01 NA versus healthy and NNA
    Eosinophils % in BALF0.5±0.21.8±0.73.0±0.9<0.01 NA versus healthy, >0.05 NA versus NNA
    Macrophages % in BALF91.5±1.090.4±2.772.4±4.9<0.01 NA versus healthy and NNA
    Lymphocytes % in BALF6.1±0.86.4±1.39.9±1.70.11 NA versus healthy and NNA
    IL-8 pg·mL−1 in BALF24.8±1.541.8±5.8138.5±42.7<0.01 NA versus healthy and NNA

    Data expressed as mean±sem unless otherwise stated. All subjects were nonsmokers. M: male; F: female; FEV1: forced expiratory volume in 1 s; BMI: body mass index; FENO: fractional exhaled nitric oxide; ACT: asthma control test; BALF: bronchoalveolar lavage fluid; IL-8: interleukin-8; N/A: not applicable.

    Supplementary Materials

    • Figures
    • Tables
    • Supplementary Material

      Please note: supplementary material is not edited by the Editorial Office, and is uploaded as it has been supplied by the author.

      Supplementary materials and methods 00474-2022.SUPPLEMENT

      Supplementary figures S1, S2, S3 and S4 00474-2022.SUPPLFIGURES

    PreviousNext
    Back to top
    Vol 9 Issue 1 Table of Contents
    ERJ Open Research: 9 (1)
    • Table of Contents
    • Index by author
    Email

    Thank you for your interest in spreading the word on European Respiratory Society .

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Bacterial DNA amplifies neutrophilic inflammation in IL-17-exposed airways
    (Your Name) has sent you a message from European Respiratory Society
    (Your Name) thought you would like to see the European Respiratory Society web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Print
    Citation Tools
    Bacterial DNA amplifies neutrophilic inflammation in IL-17-exposed airways
    Nastaran Mues, Richard J. Martin, Rafeul Alam, Niccolette Schaunaman, Kris Genelyn Dimasuay, Christena Kolakowski, Clyde J. Wright, Lijun Zheng, Hong Wei Chu
    ERJ Open Research Jan 2023, 9 (1) 00474-2022; DOI: 10.1183/23120541.00474-2022

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Share
    Bacterial DNA amplifies neutrophilic inflammation in IL-17-exposed airways
    Nastaran Mues, Richard J. Martin, Rafeul Alam, Niccolette Schaunaman, Kris Genelyn Dimasuay, Christena Kolakowski, Clyde J. Wright, Lijun Zheng, Hong Wei Chu
    ERJ Open Research Jan 2023, 9 (1) 00474-2022; DOI: 10.1183/23120541.00474-2022
    del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
    Full Text (PDF)

    Jump To

    • Article
      • Abstract
      • Abstract
      • Introduction
      • Materials and methods
      • Results
      • Discussion
      • Supplementary material
      • Acknowledgements
      • Footnotes
      • References
    • Figures & Data
    • Info & Metrics
    • PDF

    Subjects

    • Asthma and allergy
    • Lung biology and experimental studies
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    More in this TOC Section

    Original research articles

    • CT reveals hypertrophic remodelling of the diaphragm in CF
    • Association of vitamin K with lung function and disease
    • Impact of infections and probiotics on nasal microbiota
    Show more Original research articles

    Asthma

    • Shared genetic architecture of eosinophil counts and asthma
    • Identification of diurnal rhythmic blood markers in asthma
    • What bothers severe asthma patients most?
    Show more Asthma

    Related Articles

    Navigate

    • Home
    • Current issue
    • Archive

    About ERJ Open Research

    • Editorial board
    • Journal information
    • Press
    • Permissions and reprints
    • Advertising

    The European Respiratory Society

    • Society home
    • myERS
    • Privacy policy
    • Accessibility

    ERS publications

    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS books online
    • ERS Bookshop

    Help

    • Feedback

    For authors

    • Instructions for authors
    • Publication ethics and malpractice
    • Submit a manuscript

    For readers

    • Alerts
    • Subjects
    • RSS

    Subscriptions

    • Accessing the ERS publications

    Contact us

    European Respiratory Society
    442 Glossop Road
    Sheffield S10 2PX
    United Kingdom
    Tel: +44 114 2672860
    Email: journals@ersnet.org

    ISSN

    Online ISSN: 2312-0541

    Copyright © 2023 by the European Respiratory Society